Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to significant changes
in life and healthcare all over the world. Pregnant women and their newborns require extra …

Background In 2021, we showed an increased risk associated with COVID-19 in pregnancy.
Since then, the SARS-CoV-2 virus has undergone genetic mutations. We aimed to examine …

After three years of the COVID-19 pandemic, we have learned many aspects of the disease
and the virus: its molecular structure, how it infects human cells, the clinical picture at …

OBJECTIVES To evaluate the rate of postnatal infection during the first month of life in
neonates born to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive …

Infection with SARS-CoV-2 causing COVID-19 in pregnancy is known to confer risks to both
the pregnant patient and fetus. A review of the current literature demonstrates that pregnant …

Background The extent to which COVID-19 diagnosis and vaccination during pregnancy are
associated with risks of common and rare adverse pregnancy outcomes remains uncertain …

Background: The global pandemic of coronavirus disease 2019 (COVID-19) is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). About 18.4% of total Covid …

Objectives To assay the presence of the SARS-CoV-2 genome in vaginal, rectal, and
placental swabs among pregnant women and in newborn nasopharyngeal swabs and to …

Widespread SARS-CoV-2 infection among pregnant individuals has led to a generation of
fetuses exposed in utero, but the long-term impact of such exposure remains unknown …

BACKGROUND It is not known whether human fetal brain endothelial cells that form the
blood-brain barrier express angiotensin-converting enzyme 2, transmembrane serine …